ATE483983T1 - Verfahren zur diagnose von chronischem stress und verwandten erkrankungen - Google Patents

Verfahren zur diagnose von chronischem stress und verwandten erkrankungen

Info

Publication number
ATE483983T1
ATE483983T1 AT05734530T AT05734530T ATE483983T1 AT E483983 T1 ATE483983 T1 AT E483983T1 AT 05734530 T AT05734530 T AT 05734530T AT 05734530 T AT05734530 T AT 05734530T AT E483983 T1 ATE483983 T1 AT E483983T1
Authority
AT
Austria
Prior art keywords
chronic stress
related diseases
diagnosing chronic
diagnosing
stress
Prior art date
Application number
AT05734530T
Other languages
English (en)
Inventor
Marie Asberg
Ake Nygren
Rolf Ekman
Original Assignee
Randox Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Lab Ltd filed Critical Randox Lab Ltd
Application granted granted Critical
Publication of ATE483983T1 publication Critical patent/ATE483983T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/485—Epidermal growth factor [EGF] (urogastrone)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
AT05734530T 2004-04-23 2005-04-14 Verfahren zur diagnose von chronischem stress und verwandten erkrankungen ATE483983T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0409153.4A GB0409153D0 (en) 2004-04-23 2004-04-23 Method of diagnosis
PCT/GB2005/001417 WO2005103723A2 (en) 2004-04-23 2005-04-14 Method for the diagnosis of chronic stress and related disorders

Publications (1)

Publication Number Publication Date
ATE483983T1 true ATE483983T1 (de) 2010-10-15

Family

ID=32344337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05734530T ATE483983T1 (de) 2004-04-23 2005-04-14 Verfahren zur diagnose von chronischem stress und verwandten erkrankungen

Country Status (6)

Country Link
US (1) US7507584B2 (de)
EP (1) EP1743179B1 (de)
AT (1) ATE483983T1 (de)
DE (1) DE602005023973D1 (de)
GB (1) GB0409153D0 (de)
WO (1) WO2005103723A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102037355A (zh) * 2008-03-04 2011-04-27 里奇诊断学股份有限公司 基于多重生物标记物板块诊断和监测抑郁症
US8747311B2 (en) * 2009-11-19 2014-06-10 Make3Wishes, Llc Method and apparatus for evaluating the effects of internal and external stress influences

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879902A (en) 1997-06-16 1999-03-09 Neuro-Biotech Inc. Diagnostic methods and kits for the evaluation of the sympathetic nervous system function
US6653135B1 (en) 2000-09-13 2003-11-25 University Of Maryland Dynamic protein signature assay
BE1014949A3 (fr) * 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
WO2003069310A2 (en) 2002-02-14 2003-08-21 Buck Institute Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia

Also Published As

Publication number Publication date
EP1743179A2 (de) 2007-01-17
GB0409153D0 (en) 2004-05-26
EP1743179B1 (de) 2010-10-06
WO2005103723A3 (en) 2006-04-27
DE602005023973D1 (de) 2010-11-18
US20080153172A1 (en) 2008-06-26
WO2005103723A2 (en) 2005-11-03
US7507584B2 (en) 2009-03-24

Similar Documents

Publication Publication Date Title
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
DE602005015894D1 (de) Diagnostische testvorrichtung
ATE491953T1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
DE60325617D1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE518007T1 (de) Verfahren und vorrichtung zur korrelierung der ebenen von biomarker-produkten mit erkrankungen
DE60315373D1 (de) Vorrichtung und Verfahren zur Bestimmung der Konzentration von Analyten
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
ATE508202T1 (de) Verfahren zur diagnose von brustkrebs
WO2006036744A3 (en) Methods for a global assay of coagulation and fibrinolysis
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
DE602006012033D1 (de) Verfahren zur messung immunsuppressiver tacrolimus-, sirolimus- und cyclosporin-a-komplexe in einer blutprobe
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
ATE476527T1 (de) Quantifizierungsverfahren für die vegf isoformen einer biologischen probe
ATE478335T1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
DE602006017058D1 (de) Verfahren zur stratifizierung von herzinsuffizienz
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
BRPI0512948A (pt) biomarcadores de mal de alzheimer
DE602006015727D1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
NZ599054A (en) Diagnosis of collagen IX destruction
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
ATE483983T1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties